Pflügers Archiv - European Journal of Physiology

, Volume 463, Issue 3, pp 497–509

Allergic sensitization enhances anion current responsiveness of murine trachea to PAR-2 activation

  • Juraj Rievaj
  • Courtney Davidson
  • Ahmed Nadeem
  • Morley Hollenberg
  • Marek Duszyk
  • Harissios Vliagoftis
Transport Physiology

Abstract

Protease-activated receptor 2 (PAR-2) is a G protein-coupled receptor possibly involved in the pathogenesis of asthma. PAR-2 also modulates ion transport in cultured epithelial cells, but these effects in native airways are controversial. The influence of allergic inflammation on PAR-2-induced changes in ion transport has received little attention. Here, we studied immediate changes in transepithelial short circuit current (Isc) induced by PAR-2 activation in the tracheas of naive and allergic mice. Activation of PAR-2 with an apically added activation peptide (AP) induced a small increase in Isc, while a much larger increase was observed following basolateral AP addition. In ovalbumin-sensitized and -challenged animals used as a model of allergic airway inflammation, the effect of basolateral AP addition was enhanced. Responses to basolateral AP in both naive and allergic mice were not decreased by blocking sodium absorption with amiloride or CFTR function with CFTRinh172 but were reduced by the cyclooxygenase inhibitor indomethacin and largely blocked (>80%) by niflumic acid, a calcium-activated chloride channels’ (CaCC) blocker. Allergic mice also showed an enhanced response to ATP and thapsigargin. There was no change in mRNA expression of Par-2 or of the chloride channels Ano1 (Tmem16a) and Bestrophin 2 in tracheas from allergic mice, while mRNA levels of Bestrophin 1 were increased. In conclusion, basolateral PAR-2 activation in the mouse airways led to increased anion secretion through apical CaCC, which was more pronounced in allergic animals. This could be a protective mechanism aimed at clearing allergens and defending against mucus plugging.

Keywords

PAR-2 Asthma Bestrophin Airway surface liquid Calcium-activated chloride channels 

Supplementary material

424_2011_1064_MOESM1_ESM.doc (56 kb)
ESM 1(DOC 56.0 kb)

References

  1. 1.
    Abey HT, Fairlie DP, Moffatt JD, Balzary RW, Cocks TM (2006) Protease-activated receptor-2 peptides activate neurokinin-1 receptors in the mouse isolated trachea. J Pharmacol Exp Ther 317:598–605PubMedCrossRefGoogle Scholar
  2. 2.
    Anagnostopoulou P, Dai L, Schatterny J, Hirtz S, Duerr J, Mall MA (2010) Allergic airway inflammation induces a prosecretory epithelial ion transport phenotype in mice. Eur Respir J: Apr 22 [Epub ahead of print].Google Scholar
  3. 3.
    Asokananthan N, Graham PT, Stewart DJ, Bakker AJ, Eidne KA, Thompson PJ, Stewart GA (2002) House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J Immunol 169:4572–4578PubMedGoogle Scholar
  4. 4.
    Barro-Soria R, Schreiber R, Kunzelmann K (2008) Bestrophin 1 and 2 are components of the Ca(2+) activated Cl(−) conductance in mouse airways. Biochim Biophys Acta 1783:1993–2000PubMedCrossRefGoogle Scholar
  5. 5.
    Barro-Soria R, Aldehni F, Almaca J, Witzgall R, Schreiber R, Kunzelmann K (2010) ER-localized bestrophin 1 activates Ca2 + −dependent ion channels TMEM16A and SK4 possibly by acting as a counterion channel. Pflugers Arch 459:485–497PubMedCrossRefGoogle Scholar
  6. 6.
    Boitano S, Flynn AN, Sherwood CL, Schulz SM, Hoffman J, Gruzinova I, Daines MO (2011) Alternaria alternata serine proteases induce lung inflammation and airway epithelial cell activation via PAR2. Am J Physiol Lung Cell Mol Physiol: Feb 4 [Epub ahead of print].Google Scholar
  7. 7.
    Chow JM, Moffatt JD, Cocks TM (2000) Effect of protease-activated receptor (PAR)-1, -2 and −4-activating peptides, thrombin and trypsin in rat isolated airways. Br J Pharmacol 131:1584–1591PubMedCrossRefGoogle Scholar
  8. 8.
    Cloutier MM, Guernsey L, Wu CA, Thrall RS (2004) Electrophysiological properties of the airway: epithelium in the murine, ovalbumin model of allergic airway disease. Am J Pathol 164:1849–1856PubMedCrossRefGoogle Scholar
  9. 9.
    Cocks TM, Fong B, Chow JM, Anderson GP, Frauman AG, Goldie RG, Henry PJ, Carr MJ, Hamilton JR, Moffatt JD (1999) A protective role for protease-activated receptors in the airways. Nature 398:156–160PubMedCrossRefGoogle Scholar
  10. 10.
    Compton SJ, Renaux B, Wijesuriya SJ, Hollenberg MD (2001) Glycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human mast cell tryptase. Br J Pharmacol 134:705–718PubMedCrossRefGoogle Scholar
  11. 11.
    Danahay H, Withey L, Poll CT, van de Graaf SF, Bridges RJ (2001) Protease-activated receptor-2-mediated inhibition of ion transport in human bronchial epithelial cells. Am J Physiol Cell Physiol 280:C1455–C1464PubMedGoogle Scholar
  12. 12.
    Ebeling C, Forsythe P, Ng J, Gordon JR, Hollenberg M, Vliagoftis H (2005) Proteinase-activated receptor 2 activation in the airways enhances antigen-mediated airway inflammation and airway hyperresponsiveness through different pathways. J Allergy Clin Immunol 115:623–630PubMedCrossRefGoogle Scholar
  13. 13.
    Evans CM, Kim K, Tuvim MJ, Dickey BF (2009) Mucus hypersecretion in asthma: causes and effects. Curr Opin Pulm Med 15:4–11PubMedCrossRefGoogle Scholar
  14. 14.
    Holgate ST (2008) Pathogenesis of asthma. Clin Exp Allergy 38:872–897PubMedCrossRefGoogle Scholar
  15. 15.
    Hollenberg MD, Saifeddine M, al-Ani B, Kawabata A (1997) Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 75(7):832–841PubMedCrossRefGoogle Scholar
  16. 16.
    Knight DA, Lim S, Scaffidi AK, Roche N, Chung KF, Stewart GA, Thompson PJ (2001) Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J Allergy Clin Immunol 108:797–803PubMedCrossRefGoogle Scholar
  17. 17.
    Kornerup KN, Page CP, Moffatt JD (2005) Pharmacological characterisation of the adenosine receptor mediating increased ion transport in the mouse isolated trachea and the effect of allergen challenge. Br J Pharmacol 144:1011–1016PubMedCrossRefGoogle Scholar
  18. 18.
    Kreda SM, Seminario-Vidal L, van Heusden CA, O’Neal W, Jones L, Boucher RC, Lazarowski ER (2010) Receptor-promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotides. J Physiol 588:2255–2267PubMedCrossRefGoogle Scholar
  19. 19.
    Kumar RK, Herbert C, Foster PS (2008) The “classical” ovalbumin challenge model of asthma in mice. Curr Drug Targets 9(6):485–494PubMedCrossRefGoogle Scholar
  20. 20.
    Kunzelmann K, Sun J, Markovich D, Konig J, Murle B, Mall M, Schreiber R (2005) Control of ion transport in mammalian airways by protease activated receptors type 2 (PAR-2). FASEB J 19(8):969–970PubMedGoogle Scholar
  21. 21.
    Kuyper LM, Pare PD, Hogg JC, Lambert RK, Ionescu D, Woods R, Bai TR (2003) Characterization of airway plugging in fatal asthma. Am J Med 115:6–11PubMedCrossRefGoogle Scholar
  22. 22.
    Lin KW, Park J, Crews AL, Li Y, Adler KB (2008) Protease-activated receptor-2 (PAR-2) is a weak enhancer of mucin secretion by human bronchial epithelial cells in vitro. Int J Biochem Cell Biol 40:1379–1388PubMedCrossRefGoogle Scholar
  23. 23.
    Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R (2001) Proteinase-activated receptors. Pharmacol Rev 53:245–282PubMedGoogle Scholar
  24. 24.
    Mandal SK, Pendurthi UR, Rao LVM (2007) Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling. Blood 110:161–170PubMedCrossRefGoogle Scholar
  25. 25.
    Moormann C, Artuc M, Pohl E, Varga G, Buddenkotte J, Vergnolle N, Brehler R, Henz BM, Schneider SW, Luger TA, Steinhoff M (2006) Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J Invest Dermatol 126:746–755PubMedCrossRefGoogle Scholar
  26. 26.
    Nakagami Y, Favoreto S Jr, Zhen G, Park S-W, Nguyenvu LT, Kuperman DA, Dolganov GM, Huang X, Boushey HA, Avila PC, Erle DJ (2008) The epithelial anion transporter pendrin is induced by allergy and rhinovirus infection, regulates airway surface liquid, and increases airway reactivity and inflammation in an asthma model. J Immunol 181:2203–2210PubMedGoogle Scholar
  27. 27.
    Neussert R, Muller C, Milenkovic VM, Strauss O (2010) The presence of bestrophin-1 modulates the Ca2+ recruitment from Ca2+ stores in the ER. Pflugers Arch 460:163–175PubMedCrossRefGoogle Scholar
  28. 28.
    Ousingsawat J, Martins JR, Schreiber R, Rock JR, Harfe BD, Kunzelmann K (2009) Loss of TMEM16A causes a defect in epithelial Ca2 + −dependent chloride transport. J Biol Chem 284:28698–28703PubMedCrossRefGoogle Scholar
  29. 29.
    Palmer ML, Lee SY, Maniak PJ, Carlson D, Fahrenkrug SC, O’Grady SM (2006) Protease-activated receptor regulation of Cl- secretion in Calu-3 cells requires prostaglandin release and CFTR activation. Am J Physiol Cell Physiol 290:C1189–C1198PubMedCrossRefGoogle Scholar
  30. 30.
    Preston P, Wartosch L, Günzel D, Fromm M, Kongsuphol P, Ousingsawat J, Kunzelmann K, Barhanin J, Warth R, Jentsch TJ (2010) Disruption of the K+ channel β-subunit KCNE3 reveals an important role in intestinal and tracheal Cl transport. J Biol Chem 285(10):7165–7175PubMedCrossRefGoogle Scholar
  31. 31.
    Reed CE, Kita H (2004) The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 114:997–1008PubMedCrossRefGoogle Scholar
  32. 32.
    Ribeiro CM, Paradiso AM, Carew MA, Shears SB, Boucher RC (2005) Cystic fibrosis airway epithelial Ca2+ i signaling: the mechanism for the larger agonist-mediated Ca2+ i signals in human cystic fibrosis airway epithelia. J Biol Chem 280(11):10202–10209PubMedCrossRefGoogle Scholar
  33. 33.
    Rock JR, O’Neal WK, Gabriel SE, Randell SH, Harfe BD, Boucher RC, Grubb BR (2009) Transmembrane protein 16A (TMEM16A) is a Ca2 + −regulated Cl-secretory channel in mouse airways. J Biol Chem 284:14875–14880PubMedCrossRefGoogle Scholar
  34. 34.
    Sato S, Ito Y, Kondo M, Ohashi T, Ito S, Nakayama S, Shimokata K, Kume H (2005) Ion transport regulated by protease-activated receptor 2 in human airway Calu-3 epithelia. Br J Pharmacol 146:397–407PubMedCrossRefGoogle Scholar
  35. 35.
    Schmidlin F, Amadesi S, Vidil R, Trevisani M, Martinet N, Caughey G, Tognetto M, Cavallesco G, Mapp C, Geppetti P, Bunnett NW (2001) Expression and function of proteinase-activated receptor 2 in human bronchial smooth muscle. Am J Respir Crit Care Med 164:1276–1281PubMedGoogle Scholar
  36. 36.
    Schmidlin F, Amadesi S, Dabbagh K, Lewis DE, Knott P, Bunnett NW, Gater PR, Geppetti P, Bertrand C, Stevens ME (2002) Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 169:5315–5321PubMedGoogle Scholar
  37. 37.
    Schreiber R, Kunzelmann K (2005) Purinergic P2Y6 receptors induce Ca2+ and CFTR dependent Cl − secretion in mouse trachea. Cell Physiol Biochem 16:99–108PubMedCrossRefGoogle Scholar
  38. 38.
    Schreiber R, Castrop H, Kunzelmann K (2008) Allergen-induced airway hyperresponsiveness is absent in ecto-5′-nucleotidase (CD73)-deficient mice. Pflugers Arch 457:431–440PubMedCrossRefGoogle Scholar
  39. 39.
    Su X, Camerer E, Hamilton JR, Coughlin SR, Matthay MA (2005) Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J Immunol 175:2598–2605PubMedGoogle Scholar
  40. 40.
    Sun G, Stacey MA, Schmidt M, Mori L, Mattoli S (2001) Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells. J Immunol 167:1014–1021PubMedGoogle Scholar
  41. 41.
    Swystun V, Chen L, Factor P, Siroky B, Bell PD, Matalon S (2005) Apical trypsin increases ion transport and resistance by a phospholipase C-dependent rise of Ca2+. Am J Physiol Lung Cell Mol Physiol 288:L820–L830PubMedCrossRefGoogle Scholar
  42. 42.
    Takeda K, Gelfand EW (2009) Mouse models of allergic diseases. Curr Opin Immunol 21(6):660–665PubMedCrossRefGoogle Scholar
  43. 43.
    Vliagoftis H, Schwingshackl A, Milne CD, Duszyk M, Hollenberg MD, Wallace JL, Befus AD, Moqbel R (2000) Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. J Allergy Clin Immunol 106:537–545PubMedCrossRefGoogle Scholar
  44. 44.
    Vliagoftis H, Befus AD, Hollenberg MD, Moqbel R (2001) Airway epithelial cells release eosinophil survival-promoting factors (GM-CSF) after stimulation of proteinase-activated receptor 2. J Allergy Clin Immunol 107:679–685PubMedCrossRefGoogle Scholar
  45. 45.
    Yu K, Lujan R, Marmorstein A, Gabriel S, Hartzell HC (2010) Bestrophin-2 mediates bicarbonate transport by goblet cells in mouse colon. J Clin Invest 120(5):1722–1735PubMedCrossRefGoogle Scholar
  46. 46.
    Zhang Y, Stanton JB, Wu J, Yu K, Hartzell HC, Peachey NS, Marmorstein LY, Marmorstein AD (2010) Suppression of Ca2+ signaling in a mouse model of Best disease. Hum Mol Genet 19:1108–1118PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Juraj Rievaj
    • 1
    • 3
  • Courtney Davidson
    • 1
  • Ahmed Nadeem
    • 1
  • Morley Hollenberg
    • 2
  • Marek Duszyk
    • 3
  • Harissios Vliagoftis
    • 1
  1. 1.Pulmonary Research Group, Department of MedicineUniversity of AlbertaEdmontonCanada
  2. 2.Department of Pharmacology and TherapeuticsUniversity of CalgaryCalgaryCanada
  3. 3.Department of PhysiologyUniversity of AlbertaEdmontonCanada

Personalised recommendations